PositiveID Corporation, a developer of biological detection and diagnostics solutions, today announced that Chief Technology Advisor Dr. Kimothy Smith is a featured presenter at the 21st International Conference for Biodetection Technologies 2013 in Alexandria, VA, at the Hilton Alexandria Mark Center Conference Center. Dr. Smith is scheduled to present at 4 pm ET on June 18, 2013, and will discuss the Company's technological advances in the detection and identification of biological threats, specifically its M-BAND (Microfluidics-based Bioagent Autonomous Networked Detector) and Firefly Dx detection system ("Firefly").
PositiveID's M-BAND system, developed under contract with the U.S. Department of Homeland Security Science & Technology directorate, is a bio-aerosol monitor with fully integrated systems for sample collection, processing and detection modules that continuously analyze air samples for the detection of bacteria, viruses, and toxins. Results are reported via a secure wireless network in real time to give an accurate and up to date status for fielded instruments.
The goal of Firefly is to take the Company's patented molecular diagnostic technology underlying M-BAND, and implement it in a handheld device that can be used anywhere, anytime to test for biological agents. Firefly is being designed as a portable, point-of-need molecular diagnostic system to provide test results from sample input through reporting of results in less than 15 to 30 minutes depending on the type of test performed. Firefly is expected to quickly process human and agricultural samples to provide accurate confirmation of biological threats via a smart-phone application. The Company believes the target markets for Firefly include military field deployments, remote areas with limited or no access to healthcare, border locations and others.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid medical testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.